Nidhi Shah
Senior Manager, Manufacturing Operations Cellectis
Nidhi Shah is Senior Manager of Manufacturing Operations at Cellectis Biologics, where she supports the development and manufacturing of allogeneic CAR-T therapies using the company’s gene-editing platform technology. Her experience spans autologous and allogeneic cell therapy manufacturing and process development, and understanding the downstream impact of donor variability on product quality and manufacturing outcomes. Nidhi brings a valuable manufacturing perspective on identifying donor-related challenges proactively, highlighting how donor attributes can influence batch success, resource utilization, and the scalability of allogeneic cell therapy manufacturing.
Seminars
Monday 7th December 2026
Understanding the Cost of Donor Variability to Improve Product Release Success
4:30 pm
- Identifying donor-derived risks during manufacturing and testing to reduce late-stage batch failures, resource losses and release delays
- Understanding how unexpected donor characteristics impact product quality to strengthen proactive risk mitigation strategies
- Quantifying the downstream impact of donor variability on patient supply to improve manufacturing robustness and product availability
